NOTE! This site uses cookies

By continuing to browse the site you are agreeing to our use of cookies. For more detalis, see Read more


What are you looking for?

Catalan Mesoestetic Pharma Group exports 85% of its production and is present in 62 markets worldwide

The Catalan company Mesoestetic has built a new factory that multiplies by ten its previous facilities. Furthermore, the company will increase its staff by 30%. The Catalan Minister for Business and Employment has praised the company as a model for innovation and internationalisation. He has spoke of the long tradition of the pharmaceutical industry in Catalonia as well as the Catalan economy’s export capacity.


19 May 2012 12:18 AM


ACN / Bertran Cazorla

Viladecans (ACN).- The Catalan multinational company Mesoestetic Pharma Group has unveiled its new facilities located in Viladecans Business Park, next to Barcelona El Prat Airport. Mesoestetic\u2019s new factory multiplies by ten the firm\u2019s production capacity and will enable the company to increase its staff by 10%. The enterprise is leader in Catalonia for the production of cosmetic products using pharmaceutical active ingredients, the Catalan Minister for Business and Employment, Francesc Xavier Mena, pointed out. He also stressed that Mesoestetics is part of Catalonia\u2019s pharmaceutical inductry tradition, which is one of Catalonia's main industrial expertise. As Mena emphasised, the sector is particularly focused on innovation and internationalisation, two values Mesoestetics shares. It exports 85% of its production to 62 countries worldwide and allocates 40% of its profits to R&D. Mesoestetics\u2019 General Manager, Joan Carles Font, who founded the company in 1984, stated during the presentation that \u201Cbudget cuts have not been an option\u201D for them. The company\u2019s recipe for success has been, according to Font \u201Cmaking new products, investing in innovation, prioritising growth and continue opening in new markets abroad\u201D.  

Mesoestetic Pharma Group presented on Friday its new factory, labs and offices to the press, which are located in Viladecans Business Park, near Barcelona Airport. Viladecans Mayor, who also attended the presentation, explained that since the business park was created four years ago, at the beginning of the financial crisis, 2,000 jobs have been created.

40% of Mesoestetic\u2019s profits go to innovation

The new plant is 8,500 square metres and represents a \u20AC23 million investment. According to the company\u2019s own information, Mesoestetics' annual turnover was \u20AC40 million last year, and invests 40% of its profits in Research and Development. As Mena and Font emphasised, innovation is one of the company\u2019s strengths. Proof of this is the new clinical unit to develop experimental scientific studies, which are carried out prior to the release of new cosmetic products on the market. This unit is also the first of its kind to be built in Spain. The plant includes an investigation and development centre, from where the company will come up with new products for its four product lines. Mesoestetics develops cosmetic preparations, pharmaceutical products for the skin, sterile pharmaceutical products, and hygiene materials.

Developing products in cooperation with hospitals worldwide

At its new plant the Catalan multinational will make products developed in cooperation with hospitals such as Barcelona\u2019s Vall d\u2019Hebron, Geneva University, Marseille\u2019 Dermatological Laser Centre, or clinics in Switzerland, France, Austria or South Africa. Mesoestetics is completely integrated within the global market, as it exports 85% of its production and sells its products in 62 different countries worldwide, with a particular focus on South-East Asia and the United Arab Emirates (UAE).

During the presentation of Mesoestetic\u2019s new facilities in Viladecans, the Catalan Minister for Business and Employment, who is also in charge of industrial policy, stressed the Catalan economy\u2019s export drive. \u201CAs you know, Catalonia is only 6% of Spain's territory, makes up 16% of Spain\u2019s population, but the Catalan economy exports 27% of Spain\u2019s total exports\u201D, Mena said.

In addition, he also emphasised that \u201Cin Catalonia we have a good base for innovation, as Catalonia produces 1% of the world\u2019s scientific production\u201D. However, he recognised the need to invest more resources in Research and Development. \u201CWe have a challenge\u201D he said, \u201Cto increase the R&D percentage within our GDP\u201D. Font requested public powers \u201Cto continue assisting projects\u201D prioritising innovation and internationalisation, \u201Ceasing their path and removing obstacles\u201D. Mena answered reaffirming the Government\u2019s commitment. \u201CThe Government of Catalonia through the Ministry of Business and Labour is clearly committed to this joint strategy of innovation and internationalisation as a way for business competitiveness\u201D he stated.


  • One of Mesoestetic's labs in Viladecans new factory (by B. Cazorla)

  • One of Mesoestetic's labs in Viladecans new factory (by B. Cazorla)
The Catalan Minister for Business and Employment, Francesc Xavier Mena, explains Catalonia's pharmaceutical tradition and the importance of exports and innovation